{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T22:21:25Z","timestamp":1700173285912},"reference-count":19,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T00:00:00Z","timestamp":1194912000000},"content-version":"vor","delay-in-days":3118,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1999,5]]},"abstract":"<jats:p>We present a puzzling case of a 25\u2010year\u2010old depressive man suffering from seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration. We examined alleles of cytochrome P450 (CYP) isozymes. It was revealed that he was not an ultrarapid metabolizer for CYP2D6, and that the genotypes were homozygous for <jats:italic>CYP2D6 J<\/jats:italic> and heterozygous for <jats:italic>CYP2C19<\/jats:italic><jats:sub>m1<\/jats:sub>. Throughout the treatment period, his compliance was good. Since he was a smoker, it seems likely that his low clomipramine level was due to smoking\u2010induced <jats:italic>CYP1A2<\/jats:italic> activity. These findings suggest that smoking\u2010induced <jats:italic>CYP1A2<\/jats:italic> activity overcomes the possibly inhibiting effects of homozygosity for <jats:italic>CYP2D6J<\/jats:italic> and heterozygosity for <jats:italic>CYP2C19<\/jats:italic><jats:sub>ml<\/jats:sub>, and that high\u2010dose clomipramine is not always a direct cause of seizures.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1999.tb07246.x","type":"journal-article","created":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T18:01:35Z","timestamp":1194976895000},"page":"388-390","source":"Crossref","is-referenced-by-count":6,"title":["A puzzling case of seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration"],"prefix":"10.1111","volume":"99","author":[{"given":"T.","family":"Terao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Shinkai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,13]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198608000-00002"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb09933.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92086-W"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.44"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04311.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(98)90199-8"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90214-3"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000137324"},{"key":"e_1_2_1_10_2","first-page":"452","article-title":"Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation","volume":"46","author":"Johansson I.","year":"1994","journal-title":"Mol Phamacol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90242-2"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90133-2"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199310000-00005"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90004-1"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00643.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.65"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199408000-00005"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00613523"},{"key":"e_1_2_1_19_2","first-page":"1659","article-title":"The biotransformation of clomipramine in vitro: identification of the cytochrome P450s responsible for the separate metabolic pathways","volume":"277","author":"Nielsen KK","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1998)7:1 <24::AID-DA7>3.0.CO;2-F"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1999.tb07246.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1999.tb07246.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T16:05:10Z","timestamp":1698595510000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1999.tb07246.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["10.1111\/j.1600-0447.1999.tb07246.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1999.tb07246.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}